Anuh Pharma Ltd. Declares 1: 1 Bonus Issue and 30% Dividend on Post-Bonus Equity
Anuh Pharma Ltd., a leading manufacturer of Active Pharmaceutical Ingredients (APIs), is pleased to announce that its Board of Directors, at its meeting held on 23rd May 2025, has approved the issuance of bonus shares in the ratio of 1:1, i.e., one bonus share for every one equity share held by the shareholders of the Company as on the record date, which will be announced shortly. The bonus issuance is subject to the approval of the shareholders.
Further, the Board has recommended a dividend of 30% on the post-bonus equity share capital of the Company, also subject to shareholders' approval at the forthcoming Annual General Meeting (AGM)
These decisions reflect the Company's strong financial performance and reaffirm its long-standing commitment to delivering long-term value to its shareholders.
Commenting on the announcement, Mr. Ritesh Shah and Mr. Vivek Shah, Joint Managing Directors of Anuh Pharma Ltd., stated:
“The decision to issue bonus shares and declare a 30% dividend on the enhanced equity base is a reflection of Anuh Pharma's consistent growth, strong fundamentals, and our deep appreciation for the continued support and trust of our shareholders. We are confident that these initiatives will further strengthen investor confidence and reinforce our commitment to delivering sustainable value.”
Above views are of the author and not of the website kindly read disclaimer
